News

Geoffrey Ginsburg, MD, PhD, a professor of Medicine (Cardiology), Pathology, Biostatistics and Bioinformatics, and Biomedical Engineering, and a professor in School of Nursing, will leave Duke to assume the role of Chief Medical and Scientific Officer for the National Institutes of Health (NIH) All of Us Research Program, effective January 2022. In this role, Dr. Ginsburg will help direct the national scientific research agenda to improve health and accelerate research using precision medicine.

A new study by Duke researchers, including Duke Center for Applied Genomics members Deepak Voora, MD, Geoffrey Ginsburg, MD, PhD, and first author, Rachel Meyers, PhD, explores why aspirin may not work as well as expected against stroke and heart attack and to better understand any differences between low- and high-dose aspirin – one of the most commonly used medications worldwide.

CAGPM and the Duke Center for Genomic and Computational Biology (GCB) have partnered with North Carolina Central University (NCCU) for the Summer Scholars Program in Genome Sciences and Medicine, supported by an R25 grant by the National Human Genome Research Institute at NIH.

Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for November 1, 2021.

Ricardo Henao, PhD, Duke Center for Applied Genomics & Precision Medicine faculty and assistant professor in Biostatistics & Bioinformatics, collaborating with co-investigators, recently published “Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer” in Cells.

Sponsored Research 

Melissa Daubert of Cardiology has received an award from the National Institutes of Health for a project entitled "Coronary Artery Calcium i

On the heels of October highlighting breast cancer awareness and entering November when National Family Health History month is recognized, Dr. Ryanne Wu, MD, MHS, Associate Professor of Medicine and faculty at the Duke Center for Applied Genomics & Precision Medicine (CAGPM), recently completed a study on the “Development and Clinical Implementation Pilot of an Oncology-specific Risk Assessment tool in Singapore”, funded by the Duke/Duke-National University of Singapore (NUS) Research Collaboration funding mechanism.

Congratulations to three of our faculty members who are receiving distinguished academic promotions in the division of General Internal Medicine (GIM)!

In the Department of Medicine, we know that our most valuable asset is our workforce. Over the past year we have increased our focus on workforce well-being, and that’s even more important during the time of COVID-19. We have put together this web page that lists opportunities, valuable tools and resources for you to use during this challenging time.

Peer reviewer volunteers are needed to review